These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2349674)

  • 1. Studies of cyclosporine and metabolite toxicity in renal and hepatocyte culture systems.
    Bowers LD
    Transplant Proc; 1990 Jun; 22(3):1135-6. PubMed ID: 2349674
    [No Abstract]   [Full Text] [Related]  

  • 2. Sandimmun metabolites: their potential to cause adverse reactions in the rat.
    Donatsch P; Rickenbacher U; Ryffel B; Brouillard JF
    Transplant Proc; 1990 Jun; 22(3):1137-40. PubMed ID: 2349675
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppressive activity and toxicity of cyclosporine metabolites characterized by mass spectroscopy and nuclear magnetic resonance.
    Copeland KR; Yatscoff RW
    Transplant Proc; 1990 Jun; 22(3):1146-9. PubMed ID: 2349676
    [No Abstract]   [Full Text] [Related]  

  • 4. Biologic activity of cyclosporine metabolites.
    Sewing KF; Christians U; Kohlhaw K; Radeke H; Strohmeyer S; Kownatzki R; Budniak J; Schottmann R; Bleck JS; Almeida VM
    Transplant Proc; 1990 Jun; 22(3):1129-34. PubMed ID: 2349673
    [No Abstract]   [Full Text] [Related]  

  • 5. Nephrotoxicity of cyclosporine G and A in the Sprague-Dawley rat.
    Duncan JI; Simpson JG; Thomson AW; Whiting PH
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1391-2. PubMed ID: 3274338
    [No Abstract]   [Full Text] [Related]  

  • 6. Toxicologic evaluation of the new cyclosporin derivative, SDZ IMM 125, in a comparative, subchronic toxicity study in rats.
    Donatsch P; Mason J; Richardson BP; Ryffel B
    Transplant Proc; 1992 Aug; 24(4 Suppl 2):39-42. PubMed ID: 1496685
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclosporine A in contrast to a cyclosporine metabolite (OL-17) specifically inhibits growth of renal cells in culture.
    Cole E; Skorecki K; Cheung F; Wong PY; Fung LS; Levy GA
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):732-7. PubMed ID: 3388511
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular consequences of immunosuppressive drug treatment: a comparative study of cyclosporine A and cyclosporine G.
    Roullet JB; Xue H; Burdman EA; Chapman J; McCarron DA; Bennett WM
    Transplant Proc; 1995 Feb; 27(1):346-7. PubMed ID: 7879023
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative study of the effects of cyclosporine and FK 506 on rat hepatocytes cocultured with nonparenchymal liver cells.
    Namieno T; Uchino J
    Transplant Proc; 1996 Oct; 28(5):2987-90. PubMed ID: 8908147
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatocellular effects of cyclosporine A and its derivative SDZ IMM 125 in vitro.
    Wolf A; Schramm U; Fahr A; Aicher L; Cordier A; Trommer WE; Fricker G
    J Pharmacol Exp Ther; 1998 Mar; 284(3):817-25. PubMed ID: 9495838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the immunosuppressive and nephrotoxic effects of cyclosporin G.
    Hoyt EG; Hagberg RC; Billingham ME; Baldwin JC; Jamieson SW
    J Heart Transplant; 1988; 7(2):111-7. PubMed ID: 3284981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cyclosporin A and G with and without azathioprine regarding immunosuppressive efficacy, toxicity, and pharmacokinetics in Lewis rats.
    Hagberg RC; Hoyt EG; Billingham ME; Sibley RK; Starnes VA; Baldwin JC
    J Heart Transplant; 1988; 7(5):359-69. PubMed ID: 3058906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrastructural examination of glomerular and tubular changes in renal allografts with cyclosporine toxicity.
    Nacar A; Kiyici H; Oğüş E; Zağyapan R; Demirhan B; Ozdemir H; Haberal M
    Ren Fail; 2006; 28(7):543-7. PubMed ID: 17050236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of interpatient and intrapatient variation in OG 37-325 dosing requirements by the erythromycin breath test. A prospective study in renal transplant recipients.
    Turgeon DK; Leichtman AB; Blake DS; Schmouder RL; Lown KS; Annesley TM; Watkins PB
    Transplantation; 1994 Jun; 57(12):1736-41. PubMed ID: 8016878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deleterious effect of cyclosporines on the ischemic kidney in the rat and protection by the calcium antagonist verapamil.
    Ar'Rajab A; Dawidson IJ; Sentementes JT; Harris RB
    Transplant Proc; 1994 Oct; 26(5):2894-5. PubMed ID: 7940914
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term graft acceptance in allografted rats and dogs by treatment with a novel immunosuppressant, FTY720.
    Suzuki S; Enosawa S; Kakefuda T; Amemiya H; Hoshino Y; Chiba K
    Transplant Proc; 1996 Jun; 28(3):1375-6. PubMed ID: 8658701
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclosporine in transplantation of the liver in the dog.
    Williams JW; Peters TG; Haggitt R; Van Voorst S
    Surg Gynecol Obstet; 1983 Jun; 156(6):767-73. PubMed ID: 6344281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Induction of long-term tolerance by cyclosporine in orthotopic kidney allografts in rats].
    Rodríguez J; Jiménez G; Arias J; Aller MA; Lorente L; Arias L; Arias JI; Brandau D; Durán H
    Arch Esp Urol; 1987 May; 40(4):235-40. PubMed ID: 3307645
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experimental studies of the nephroprotective effect of fosfomycin].
    Kreft B; Marre R; Schulz E; Sack K
    Wien Med Wochenschr; 1987 Feb; 137(4):83-8. PubMed ID: 2954305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of verapamil on hepatorenal toxicity induced by cyclosporin].
    Aller Reyero MA; Arias Pérez J; Lorente Ruigómez L; Arias Fernández L; Trovo Muñiz JI; Brandau Ballnet D; Durán Sacristán H
    Arch Esp Urol; 1989; 42(9):847-50. PubMed ID: 2624484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.